Clal Insurance Enterprises (CLIS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
10 Nov, 2026Executive summary
Q1 2025 net income was NIS 408M vs. NIS 315M; comprehensive income attributable to shareholders was NIS 409M vs. NIS 314M.
Pre-tax core income rose 15% to NIS 522M from NIS 454M, supported by stronger insurance underwriting and credit-card activity.
Higher risk-free interest rates reduced insurance liabilities, partly offset by lower capital-market investment returns.
Financial highlights
Pretax income was NIS 605M vs. NIS 480M; income tax expense was NIS 197M vs. NIS 165M.
Basic EPS was NIS 5.12 vs. NIS 3.97; diluted EPS was NIS 4.96 vs. NIS 3.96.
Total assets were NIS 171.6B at March 31, 2025 vs. NIS 173.0B at December 31, 2024; shareholders’ equity was NIS 9.154B vs. NIS 8.742B.
Operating cash flow after tax was NIS 687M; investing and financing cash use was NIS 487M and NIS 453M; cash and equivalents ended at NIS 6.83B.
Q1 2024 included a one-time NIS 18M increase in tax expense from tax-rate changes and prior-year assessment closures.
Segment performance
Insurance and savings underwriting income before tax rose to NIS 252M from NIS 203M; premiums, contributions and investment-contract proceeds reached NIS 6.9B vs. NIS 6.7B.
P&C comprehensive income was NIS 69M vs. NIS 38M; motor-property combined ratio improved to 90% from 99%, while gross premiums fell to NIS 1.072B from NIS 1.129B.
Health insurance comprehensive income was NIS 113M vs. NIS 60M; gross premiums rose to NIS 481M from NIS 435M.
Credit-card segment revenue was NIS 621M vs. NIS 547M and pretax income was NIS 118M vs. NIS 93M; Max net profit rose 36% to NIS 79M.
Max active cards reached 3.3M, up 8.7% YoY; non-banking card issuance turnover increased 18.7%.
Latest events from Clal Insurance Enterprises
- Markets and P&C gains restored profitability, while health reserves and war uncertainty weighed.CLIS
Q1 2024 - H1 returned to profit on stronger underwriting and card results despite weak markets.CLIS
Q2 2024 - 9M comprehensive income reached NIS 596m, supported by stronger investment returns and underwriting.CLIS
Q3 2024 - 2024 comprehensive income rose to NIS 956m as insurance and MAX expanded earnings.CLIS
Q4 2024 - H1 core income rose modestly as strong insurance results met Q2 softness and a VAT provision.CLIS
Q2 2025 - 9M earnings and AUM grew, with results absorbing a one-off VAT provision.CLIS
Q3 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026